Clinical Trials Directory

Trials / Conditions / Recurrent Adult Immunoblastic Lymphoma

Recurrent Adult Immunoblastic Lymphoma

6 registered clinical trials studyying Recurrent Adult Immunoblastic Lymphoma.

StatusTrialSponsorPhase
TerminatedIbrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
NCT02109224
National Cancer Institute (NCI)Phase 1
CompletedAlisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-C
NCT01567709
National Cancer Institute (NCI)Phase 1
CompletedVeliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma
NCT01326702
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedLenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers
NCT01254578
National Cancer Institute (NCI)Phase 1
CompletedDasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surg
NCT00608361
National Cancer Institute (NCI)Phase 1
CompletedTacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease i
NCT00105001
Fred Hutchinson Cancer CenterPhase 2